When was Nebula Genomics founded?

Nebula Genomics was founded in 2016 and raised its 1st funding round 2 years after it was founded.

Where is Nebula Genomics located?

Nebula Genomics is headquartered in San Francisco, United States. It is registered at San Francisco, California.

How many employees does Nebula Genomics have?

As of Jun 30, 2026, the latest employee count at Nebula Genomics is 13.

Is Nebula Genomics a funded company?

Nebula Genomics is a funded company, having raised a total of $***** in its 1st and only funding round, a Seed round on Aug 29, 2018.

When was the latest funding round of Nebula Genomics?

Nebula Genomics' latest funding was a $***** Seed round on Aug 29, 2018, with participation from 11 investors. Its primary sector is Genomics. In United States, the Genomics sector has seen $1.35B in funding in 2026 to date.

Where does Nebula Genomics rank among its competitors?

Nebula Genomics ranks 11th amongst 85 active competitors, of which 13 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Genomind, which secured $400K in Feb, 2025.

Who are the top competitors of Nebula Genomics?

Nebula Genomics' top competitors include 23andMe, Helix and Color. Among them, Genomind secured the most recent funding round in February, 2025.

Nebula Genomics - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of DNA Sequencing technology for personal genomics. The company also provides a health big database by genomic sequencing for consumers, researchers, and the medical community. The company uses blockchain to ensure that consumers maintain control of the data obtained from DNA analysis. The database is used by researchers for drug development, streamlining clinical trials, and personalized medicine.

Website: nebula.org
Social
Email ID: *****@nebula.org
Registered Address: San Francisco, California

Key Metrics

Founded Year

2016

Location

San Francisco, United States

Stage

Acquired

Total Funding

$4.3M in 1 round

Latest Funding Round

Seed, Aug 29, 2018, $*****

Investors

Khosla Ventures & 13 more

Ranked

11^th among 85 active competitors

Employee Count

13 as on Jun 30, 2026

Similar Companies

23andMe & 175 more

Exit Details

Acquired by ProPhase Labs (Aug 11, 2021)

View Nebula Genomics' full profile

Nebula Genomics is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
NEBULA GENOMICS, INC. CIN: 824685487 , United States, Active	Dec 26, 999	-	2 (As on Dec 31, 2024)	-

Nebula Genomics got acquired by ProPhase Labs on Aug 11, 2021 at an acquisition amount of $*****.

Click here to take a look at Nebula Genomics's acquisition in detail

Nebula Genomics has raised a total funding of $4.3M over 1 round. Its latest funding round was a Seed round on Aug 29, 2018 for $*****. 11 investors participated in its latest round. Nebula Genomics has 14 institutional investors.

Here is the list of recent funding rounds of Nebula Genomics:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Aug 29, 2018	1242544	Seed	3793750	6261271	7498935	8583322

Access funding benchmarks and valuations. Sign up today!

View details of Nebula Genomics's funding rounds and investors

The founders of Nebula Genomics are George Church and Dennis Grishin.

Here are the details of Nebula Genomics' key team members:

George Church: Co-Founder of Nebula Genomics and founder of 1 other company.
Contact Info: 1 email address
Dennis Grishin: Former Co-Founder of Nebula Genomics.
Contact Info: 1 email address

View details of Nebula Genomics's Founder profiles and Board Members

Nebula Genomics' employee count trend

Nebula Genomics has 13 employees as of Jun 26. Here is Nebula Genomics's employee count trend over the years:

Employee count trend for Nebula Genomics

Uncover Nebula Genomics' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Nebula Genomics include 23andMe, Helix and Color. Here is the list of Top 10 competitors of Nebula Genomics, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	23andMe 2006, Sunnyvale (United States), Acquired	Provider of genetic test solutions to study ancestry, genealogy, and inherited traits	$944M	Google Ventures, Fidelity Investments & 34 others	77/100
2nd	Helix 2015, San Francisco (United States), Series E	Provider of a genomic database for clinical research	$435M	DFJ Growth, Kleiner Perkins & 12 others	71/100
3rd	Color 2013, Burlingame (United States), Series E	Provider of end-to-end Virtual clinic offering cancer-based solutions	$491M	General Catalyst, T. Rowe Price & 46 others	66/100
4th	Nucleus Genomics 2021, Manhattan (United States), Series A	Provider of genetic testing kits for rare variant analysis	$32M	Founders Fund, Quiet Capital & 27 others	62/100
5th	Genomind 2009, King Of Prussia (United States), Series C	Developer of genetic tests for personalised medicines to enhance mental health treatment	$64.4M	Claritas Capital, SVB & 1 others	56/100
6th	Veritas Genetics 2014, Danvers (United States), Acquired	Provider of genetic testing products	$53.4M	Trustbridge Partners, Simcere Pharma & 6 others	55/100
7th	Counsyl 2007, San Francisco (United States), Acquired	DNA mapping for pre-pregnancy genetic testing, DNA and cancer screening	$113M	Perceptive Advisors, Y Ventures & 14 others	54/100
8th	Digbi Health 2018, Mountain View (United States), Series A	Provider of personalized healthcare on basis of DNA testing	$8.5M	Accel, Ocean Azul Partners & 9 others	49/100
9th	Recombine 2011, New York City (United States), Acquired	Genetic testing services	$12.1M	FirstMark, Vast Ventures & 3 others	48/100
10th	SelfDecode 2016, San Luis Obispo (United States), Series A	Provider of personal genome analysis service	$8M	BoxOne Ventures & 2 others	46/100
11th	Nebula Genomics 2016, San Francisco (United States), Acquired	Developer of DNA Sequencing technology for personal genomics	$4.3M	CampVentures, F-Prime Capital & 12 others	46/100